Matrix Capital Management Exits Aura Biosciences with $39M Share Repurchase
AURA sits 88% above its 52-week low of $4.345.
Summary
Aura Biosciences completed a $39 million share repurchase from Matrix Capital Management, marking the investment firm's full exit as a shareholder.
Key Events · Ownership and Investor Activity · AURA
-
Major Share Repurchase Completed
Aura Biosciences repurchased 6,922,870 shares of common stock from Matrix Capital Management Company LP at $5.64 per share, totaling approximately $39.04 million. This transaction was completed on May 7, 2026, following a definitive agreement announced on May 4, 2026.
-
Significant Investor Exits
Matrix Capital Management Company LP, a former 10% owner, has fully divested its stake in Aura Biosciences. This Schedule 13D/A serves as an "exit filing" for the reporting persons, indicating they no longer hold any shares.
Analysis · AURA · Life Sciences
This filing confirms the completion of Aura Biosciences' repurchase of 6.92 million shares from Matrix Capital Management Company LP for $39 million. This transaction, previously announced in an 8-K on May 4, 2026, marks the complete exit of Matrix Capital Management as a significant shareholder. The repurchase reduces the outstanding share count and follows recent capital raises, indicating the company's active capital management.
How filings like this one have moved
In the 30 days to Oct 1, 2026, 36.1% of the 1051 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.56%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, AURA was trading at $8.19 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $525.8M. The 52-week trading range was $4.35 to $9.54. This filing was assessed with neutral market sentiment and an importance score of 8 out of 10.